To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

T-cell acute lymphoblasti… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Journal article
Authors P Quist-Paulsen
N Toft
M Heyman
Jonas Abrahamsson
L Griškevičius
H Hallböök
Ó G Jónsson
K Palk
G Vaitkeviciene
K Vettenranta
A Åsberg
T L Frandsen
S Opdahl
H V Marquart
S Siitonen
L T Osnes
M Hultdin
U M Overgaard
U Wartiovaara-Kautto
K Schmiegelow
Published in Leukemia
Volume 34
Issue 2
Pages 347-57
ISSN 1476-5551
Publication year 2020
Published at Institute of Clinical Sciences, Department of Pediatrics
Pages 347-57
Language en
Subject categories Pediatrics


The NOPHO ALL2008 is a population-based study using an unmodified pediatric protocol in patients 1-45 years of age with acute lymphoblastic leukemia. Patients with T-ALL were given a traditional pediatric scheme if fast responding (minimal residual disease (MRD) < 0.1% day 29), or intensive block-based chemotherapy if slow responding (MRD > 0.1% day 29). Both treatment arms included pediatric doses of high-dose methotrexate and asparaginase. If MRD ≥ 5% on day 29 or ≥0.1% after consolidation, patients were assigned to allogeneic hematopoietic stem cell transplantation. The 5-year overall survival of the 278 T-ALL patients was 0.75 (95% CI 0.69-0.81), being 0.82 (0.74-0.88) for patients 1.0-9.9 years, 0.76 (0.66-0.86) for those 10.0-17.9 years, and 0.65 (0.55-0.75) for the older patients. The risk of death in first remission was significantly higher in adults (12%) compared with the 1-9 years group (4%). The MRD responses in the three age groups were similar, and only a nonsignificant increase in relapse risk was found in adults. In conclusion, an unmodified pediatric protocol in patients 1-45 years is effective in all age groups. The traditional pediatric treatment schedule was safe for all patients, but the intensive block therapy led to a high toxic death rate in adults.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?